Publications and communications of Etienne BAUDOUX

Chabannon, C., Benakli, M., Alexandrova, K., Coze, C., Dalle, J.-H., Giraud, C., Huynh, P., Kanouni, T., Kanold, J., Lesieur, I., Levavasseur, A., Yakoub-Agha, I., & Baudoux, E. (2024). Cytaphérèses pédiatriques (atelier SFGM-TC). Bulletin du Cancer. doi:10.1016/j.bulcan.2023.12.008

Delgadillo, J., Kerkelä, E., Waters, A., van den Akker, E., LECHANTEUR, C., BAUDOUX, E., Gardiner, N., De Vos, J., & Vives, J. (2023). A management model in blood, tissue and cell establishments to ensure rapid and sustainable patient access to advanced therapy medicinal products in Europe. Cytotherapy. doi:10.1016/j.jcyt.2023.08.001

Reenaers, C., GILLARD, R., Coimbra, C., GILLARD, R., Meunier, P., LECHANTEUR, C., BAUDOUX, E., BOUTAFFALA, L., Beguin, Y., & Louis, E. (2023). Clinical and MRI evolution after local injection of bone marrow-derived mesenchymal stem cells in perianal fistulae in Crohn’s disease: results from a prospective monocentric study. Journal of Crohn's and Colitis, 17, 728-737. doi:10.1093/ecco-jcc/jjac192

Servais, S., Baron, F., LECHANTEUR, C., Seidel, L., BAUDOUX, E., BRIQUET, A., Selleslag, D., Maertens, J., Poire, X., Schroyens, W., Graux, C., De Becker, A., Zachee, P., Ory, A., Herman, J., Kerre, T., & Beguin, Y. (2023). Multipotent mesenchymal stromal cells as treatment for poor graft function after allogeneic hematopoietic cell transplantation: A multicenter prospective analysis. Frontiers in Immunology, 14. doi:10.3389/fimmu.2023.1106464

GREGOIRE, C.* , LAYIOS, N.* , LAMBERMONT, B., LECHANTEUR, C., BRIQUET, A., Bettonville, V., BAUDOUX, E., THYS, M., Dardenne, N., Misset, B.* , & BEGUIN, Y.*. (04 July 2022). Bone Marrow-Derived Mesenchymal Stromal Cell Therapy in Severe COVID-19: Preliminary Results of a Phase I/II Clinical Trial. Frontiers in Immunology, 13, 932360. doi:10.3389/fimmu.2022.932360

Forcade, E., Bacquet, S., Ballot, C., Capin, L., GARNIER, F., Giraud, C., Guérout-Vérité, M.-A., Letellier, C., MAGNANI, A., MAMEZ, A.-C., NASONE, J., Sinayoko, M., BAUDOUX, E., MIALOU, V., Yakoub-Agha, I., & Calmels, B. (2022). Modalités et impact de la cryopréservation des greffons allogéniques en contexte pandémique : recommandations de la Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). Bulletin du Cancer. doi:10.1016/j.bulcan.2022.03.015

VIEUJEAN, S., LOLY, J.-P., BOUTAFFALA, L., MEUNIER, P., REENAERS, C., BRIQUET, A., LECHANTEUR, C., BAUDOUX, E., BEGUIN, Y., & LOUIS, E. (2022). Mesenchymal Stem Cell Injection in Crohn's Disease Strictures: a phase I-II clinical study. Journal of Crohn's and Colitis, 16, 506-510. doi:10.1093/ecco-jcc/jjab154

Ingels, J., De Smet, S., Heyns, K., Lootens, N., Segaert, J., Taghon, T., Leclercq, G., Vermaelen, K., WILLEMS, E., BAUDOUX, E., Kerre, T., Baron, F., & Vandekerckhove, B. (2021). Treatment of a patient with severe cytomegalovirus (CMV) infection after haploidentical stem cell transplantation with donor-derived CMV-specific T cells. Acta Clinica Belgica: International Journal of Clinical and Laboratory Medicine, 76, 482-486. doi:10.1080/17843286.2020.1752446

Jöris, M., Paulson, K., Foley, L., Duffy, M., Querol, S., Gomez, S., & BAUDOUX, E. (2021). Worldwide survey on key indicators for public cord blood banking technologies: By the World Marrow DonorAssociation Cord Blood Working Group. Stem Cells Translational Medicine, 10, 222-229. doi:10.1002/sctm.20-0246

LECHANTEUR, C., BRIQUET, A., Bettonville, V., BAUDOUX, E., & BEGUIN, Y. (2021). MSC Manufacturing for Academic Clinical Trials: From a Clinical-Grade to a Full GMP-Compliant Process. Cells, 10, 1320. doi:10.3390/cells10061320

Calmels, B., Gautier, E., Magnani, A., Magrin, E., Mamez, A. C., Vaissié, A., Yakoub-Agha, I., & BAUDOUX, E. (2020). Procédé de préparation, contrôles de qualité et spécifications des immunosélections CD34+ : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC). Bulletin du Cancer. doi:10.1016/j.bulcan.2020.06.005

Dalle, J.-H., BAUDOUX, E., Caillat-Zucman, S., Colledani, F., PEREIRA-MARTINS, M., Bruno, B., Nguyen, S., Robin, M., & Rubio, M. T. (April 2020). Le développement des cellules CAR-T et autre thérapie génique : tout n’est pas si simple [letter to the editor]. Bulletin du Cancer, 107 (4), 408-409. doi:10.1016/j.bulcan.2020.03.002

HAUZEUR, J.-P., LECHANTEUR, C., BAUDOUX, E., De Maertelaer, V., Pather, S., Katz, R., Malaise, M., Ino, J., & Beguin, Y. (2020). Did Osteoblastic Cell Therapy Improve the Prognosis of Prefracture Osteonecrosis of the Femoral Head? A Randomized, Controlled Trial. Clinical Orthopaedics and Related Research, 478, 1307-1315.

De Vos, J., BAUDOUX, E., Bay, J.-O., Calmels, B., Cras, A., El Cheikh, J., Guerout-Verite, M.-A., Lacassagne, M.-N., Lamure, S., Letellier, C., Menard, A.-L., Daguindau, E., Poiré, X., Yakoub-Agha, I., & Guillaume, T. (December 2019). Injections de lymphocytes du donneur (DLI) : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC). Bulletin du Cancer, 106, 35-S39. doi:10.1016/j.bulcan.2018.10.002

ERPICUM, P., WEEKERS, L., DETRY, O., BONVOISIN, C., DELBOUILLE, M.-H., GREGOIRE, C., BAUDOUX, E., BRIQUET, A., LECHANTEUR, C., MAGGIPINTO, G., SOMJA, J., Pottel, H., Baron, F., Jouret, F., & BEGUIN, Y. (2019). Infusion of third-party mesenchymal stromal cells after kidney transplantation: a phase I-II, open-label, clinical study. Kidney International, 95, 693-707. doi:10.1016/j.kint.2018.08.046

de Jamblinne, Y., BAUDOUX, E., Delo, C., & Coppieters, Y. (August 2018). Influence de facteurs obstétricaux sur les caractéristiques des greffons de sang de cordon ombilical. Gynécologie Obstétrique et Fertilité, 46, 639-644. doi:10.1016/j.gofs.2018.07.005

HAUZEUR, J.-P., De Maertelaer, V., BAUDOUX, E., MALAISE, M., Beguin, Y., & Gangji, V. (2018). Inefficacy of autologous bone marrow concentrate in stage three osteonecrosis: a randomized controlled double-blind trial. International Orthopaedics, 42, 1429-1435. doi:10.1007/s00264-017-3650-8

Servais, S., Baron, F., LECHANTEUR, C., SEIDEL, L., Selleslag, D., Maertens, J., BAUDOUX, E., Zachee, P., Van Gelder, M., Noens, L., Kerre, T., Lewalle, P., Schroyens, W., ORY, A., & Beguin, Y. (2018). Infusion of bone marrow derived multipotent mesenchymal stromal cells for the treatment of steroid-refractory acute graftversus- host disease: A multicenter prospective study. Oncotarget, 9 (29), 20590-20604. doi:10.18632/oncotarget.25020

DETRY, O., VANDERMEULEN, M., DELBOUILLE, M.-H., SOMJA, J., BLETARD, N., Briquet, A., LECHANTEUR, C., GIET, O., BAUDOUX, E., Hannon, M., Baron, F., & Beguin, Y. (July 2017). Infusion of mesenchymal stromal cells after deceased liver transplantation: A phase I-II, open-label, clinical study. Journal of Hepatology, 67 (1), 47-55. doi:10.1016/j.jhep.2017.03.001

GREGOIRE, C., LECHANTEUR, C., BRIQUET, A., BAUDOUX, E., BARON, F., LOUIS, E., & BEGUIN, Y. (2017). Review article: mesenchymal stromal cell therapy for inflammatory bowel diseases. Alimentary Pharmacology and Therapeutics, 45, 205-221. doi:10.1111/apt.13864

Nikolajeva, O., Rocha, V., Danby, R., Ruggeri, A., Volt, F., BAUDOUX, E., Gomez, S. G., Kögler, G., Larghero, J., Lecchi, L., Sanchez Martinez, M., Navarrete, C., Pouthier, F., Querol, S., Kenzey, C., Szydlo, R., Gluckman, E., & Madrigal, A. (2017). Umbilical Cord Blood Cytomegalovirus Serostatus Does Not Have an Impact on Outcomes of Umbilical Cord Blood Transplantation for Acute Leukemia. Biology of Blood and Marrow Transplantation. doi:10.1016/j.bbmt.2017.06.022

Boulanger, F., Decot, V., Bulliard, G., Calmels, B., Giraud, C., Lacassagne, M. N., Magnani, A., Pouthier, F., Thibert, J. B., Tirefort, Y., Yakoub-Agha, I., & BAUDOUX, E. (2016). Modalités de préparation, cryopréservation, décongélation des cellules souches hématopoïétiques et précautions pour infusion au patient: recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC). Bulletin du Cancer. doi:10.1016/j.bulcan.2016.09.002

Saccardi, R., Tucunduva, L., Ruggeri, A., Ionescu, I., Koegler, G., Querol, S., Grazzini, G., Lecchi, L., Nanni Costa, A., Navarrete, C., Pouthier, F., Larghero, J., Regan, D., Freeman, T., Bittencourt, H., Kenzey, C., Labopin, M., BAUDOUX, E., Rocha, V., & Gluckman, E. (31 May 2016). Impact of cord blood banking technologies on clinical outcome: a Eurocord/Cord Blood Committee (CTIWP), European Society for Blood and Marrow Transplantation and NetCord retrospective analysis. Transfusion, 56 (8), 2021-2029. doi:10.1111/trf.13661

LECHANTEUR, C., BRIQUET, A., GIET, O., DELLOYE, O., BAUDOUX, E., & BEGUIN, Y. (2016). Clinical - scale expansion of mesenchymal stromal cells: a large banking experience. Journal of Translational Medicine, 14, 145-159. doi:10.1186/s12967-016-0892-y

SERVAIS, S., GREGOIRE, C., BARON, F., WILLEMS, E., BRIQUET, A., BAUDOUX, E., DELLOYE, O., GIET, O., LECHANTEUR, C., & BEGUIN, Y. (2016). Multipotent mesenchymal stromal cell therapy for steroid-refractory acute graft-versus-host disease after allogeneic stem cell transplantation. Belgian Journal of Hematology, 7, 229-235.

Rouard, H., Boulanger, F., BAUDOUX, E., Calmels, B., de Vos, J., Gautier, E., Lacassagne, M. N., Tirefort, Y., Turlure, P., Chabannon, C., GERARD, C., GIET, O., Letellier, C., MONFORT, M., Thibert, J.-B., & Yakoub-Agha, I. (December 2015). Bone marrow processing for hematopoietic stem cell transplantation: recommendations of the SFGM-TC. Hématologie, 21 (Supp 3), 42-46. doi:10.1684/hma.2015.1070

Pirnay, J. P., BAUDOUX, E., Cornu, O., Delforge, A., Delloye, C., Guns, J., Heinen, E., Van den Abbeel, E., Vanderkelen, A., Van Geyt, C., van Riet, I., Verbeken, G., De Sutter, P., Verlinden, M., Huys, I., Cockbain, J., Chabannon, C., Dierickx, K., Schotsmans, P., ... Sterckx, S. (07 April 2015). Access to human tissues for research and product development. EMBO Reports, 16 (5), 1-6. doi:10.15252/embr.201540070

Binsfeld, M., HANNON, M., Otjacques, E., Humblet-Baron, S., BAUDOUX, E., BEGUIN, Y., BARON, F., & CAERS, J. (2015). Impact of the immunomodulating peptide thymosin alpha 1 on multiple myeloma and immune recovery after hematopoietic stem cell transplantation. Cancer Immunology, Immunotherapy, 64, 989-998. doi:10.1007/s00262-015-1708-2

Saccardi, R., Azqueta, C., Ballerini, C., Ballerini, L., BAUDOUX, E., Caporale, R., Dal Pozzo, S., Gomez, S., Kogler, G., Lanza, F., Angelotti, M., Madrigal, A., Ongari, M., Querol, S., Radke, T., Rocha, V., Ruggeri, A., Urbani, S., & Gluckman, E. (2015). Modification of standard ISHAGE methodology for CD34+ cells count on thawed Cord Blood Units: results from a multi-center Eurocord/Netcord study. Bone Marrow Transplantation, 50, 562.

Servais, S., BAUDOUX, E., Brichard, B., Bron, D., Debruyn, C., De Bruyère, M., De Hemptinne, D., Deneys, V., Paulus, J.-M., Raymakers, N., Schaaps, J.-P., Van Cauwenberge, J., Cornu, G., Delforge, A., & Beguin, Y. (January 2015). Circadian and circannual variations in cord blood hematopoietic cell composition. Haematologica, 100 (1), 32-34. doi:10.3324/haematol.2014.115394

SACCARDI, R., AZQUETA, C., BALLERINI, L., BAUDOUX, E., DAL POZZO, S., GOMEZ, S., KOGLER, G., LANZA, F., ONGARI, M., QUEROL, S., FALK RADKE, T., ROCHA, V., RUGGERI, A., URBANI, S., & GLUCKMAN, E. (06 December 2014). Flow Cytometry Assessment of CD34+ Viability in Thawed Cord Blood Units: A Multi-Center Eurocord and Netcord Study. Blood, 124.

DETRY, O., JOURET, F., VANDERMEULEN, M., ERPICUM, P., Delens, L., GREGOIRE, C., BRIQUET, A., WEEKERS, L., BAUDOUX, E., LECHANTEUR, C., & BEGUIN, Y. (December 2014). Cellules stromales mésenchymateuses et transplantation d'organes. Revue Médicale de Liège, 69, 53-56.

RUGGERI, A., LABOPIN, M., SORMANI, M. P., SANZ, G., SANZ, J., VOLT, F., MICHEL, G., LOCATELLI, F., DIAZ DE HEREDIA, C., O’BRIEN, T., ARCESE, W., IORI, A. P., QUEROL, S., KOGLER, G., LECCHI, L., POUTHIER, F., GARNIER, F., NAVARRETE, C., BAUDOUX, E., ... SACCARDI, R. (September 2014). Engraftment kinetics and graft failure after single umbilical cord blood transplantation using a myeloablative conditioning regimen. Haematologica, 99, 1509-1515. doi:10.3324/haematol.2014.109280

CALMELS, Boulanger, F., BAUDOUX, E., Decot, V., Fawaz, A., Giraud, C., Hivert, B., Garderet, L., Milpied, N., & Yakoub-Agha. (01 July 2014). Modalités de conservation et de destruction des produits cellulaires cryopréservés : recommandations de la SFGM-TC. Pathologie Biologie, 62 (3). doi:10.1016/j.patbio.2014.05.006

De Vos, J., Birebent, B., Faucher, C., GIET, O., Hicheri, Y., Lemarie, C., BAUDOUX, E., Garnier, F., Larghero, J., Pouthier, F., Thibert, J., & Yakoub-Agha, I. (2014). Contrôle de qualité des USP via segments attachés : recommandations de la SFGM-TC. Pathologie Biologie. doi:10.1016/j.patbio.2014.05.005

Hannon, M., LECHANTEUR, C., Lucas, S., Somja, J., Seidel, L., Belle, L., Bruck, F., BAUDOUX, E., GIET, O., Chantillon, A.-M., Delvenne, P., Drion, P., Beguin, Y., Humblet-Baron, S., & Baron, F. (17 June 2014). Infusion of clinical-grade enriched regulatory T cells delays experimental xenogeneic graft-versus-host disease. Transfusion, 54 (February), 353-363. doi:10.1111/trf.12279

Baron, F., Humblet-Baron, S., Ehx, G., SERVAIS, S., HANNON, M., Belle, L., LECHANTEUR, C., BRIQUET, A., GIET, O., BAUDOUX, E., WILLEMS, E., & Beguin, Y. (2014). Thinking out of the box - New approaches to controlling GVHD. Current Hematologic Malignancy Reports, 9, 73-84. doi:10.1007/s11899-013-0187-9

LECHANTEUR, C., Baila, S., Janssen, M. E., GIET, O., BRIQUET, A., BAUDOUX, E., & Beguin, Y. (2014). Large-Scale Clinical Expansion of Mesenchymal Stem Cells in the GMP-Compliant, Closed Automated Quantum® Cell Expansion System: Comparison with Expansion in Traditional T-Flasks. Journal of Stem Cell Research and Therapy, 4 (8), 1000222. doi:10.4172/2157- 7633.1000222

MOERMANS, C., LECHANTEUR, C., BAUDOUX, E., GIET, O., HENKET, M., SEIDEL, L., LEJEUNE, M., WILLEMS, E., Baron, F., LOUIS, R., & BEGUIN, Y. (2014). Impact of cotransplantation of mesenchymal stem cells on lung function after unrelated allogeneic hematopoietic stem cell transplantation following non-myeloablative conditioning. Transplantation, 98 (3), 348-353. doi:10.1097/TP.0000000000000068

Klykens, J., Pirnay, J., Verbeken, G., GIET, O., BAUDOUX, E., Jashari, R., Vanderkelen, A., & Ectors, N. (2013). Cleanrooms and tissue banking how happy I could be with either GMP or GTP? Cell and Tissue Banking. doi:10.1007/s10561-012-9355-8

Rocha, V., Spellman, S., Zhang, M., Ruggeri, A., Purtill, D., Brady, C., Baxter-Lowe, L., BAUDOUX, E., Bergamaschi, P., Chow, R., Freed, B., Koegler, G., Kurtzberg, J., Larghero, J., Lecchi, L., Nagler, A., Navarette, C., Prasad, V., Pouthier, F., ... Eapen, M. (2012). Effect of HLA-matching recipients to donor non-inherited maternal antigens on outcomes after mismatched umbilical cord blood transplantation for hematologic malignancy. Biology of Blood and Marrow Transplantation.

PIRNAY, J., ECTORS, N., DELLOYE, C., DUFRANE, D., BAUDOUX, E., VAN BRUSSEL, M., CASAER, M., DE VOS, D., DRAYE, J., ROSE, T., JENNES, S., NEIRINCKX, P., LAIRE, G., ZIZI, M., & VERBEKEN, G. (2012). Beware of the commercialization of human cells and tissues: situation in the European Union. Cell and Tissue Banking. doi:10.1007/s10561-012-9323-3

GLUCKMAN, E., ROCHA, V., BAUDOUX, E., BOO, M., KURTZBERG, J., WELTE, K., NAVARRETE, C., & VAN WALRAVEN, S. (12 July 2011). Family-directed umbilical cord blood banking. Haematologica, 96 (11), 1700-17007. doi:10.3324/haematol.2011.047050

Baron, F., Lechanteur, C., Willems, E., Bruck, F., Baudoux, E., Seidel, L., Vanbellinghen, J.-F., Hafraoui, K., LEJEUNE, M., Gothot, A., Fillet, G., & Beguin, Y. (2010). Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning. Biology of Blood and Marrow Transplantation, 16 (6), 838-47. doi:10.1016/j.bbmt.2010.01.011

Willems, E.* , Baron, F.* , Baudoux, E., Wanten, N., Seidel, L., Vanbellinghen, J.-F., Herens, C., Gothot, A., Frere, P., Bonnet, C., Hafraoui, K., Vanstraelen, G., Fillet, G., & Beguin, Y. (2009). Non-myeloablative transplantation with CD8-depleted or unmanipulated peripheral blood stem cells: a phase II randomized trial. Leukemia, 23 (3), 608-10. doi:10.1038/leu.2008.248

Brand, A., Rebulla, P., Engelfriet, C. P., Reesink, H. W., Beguin, Y., Baudoux, E., Kögler, G., Ebrahimi, M., Grazzini, G., Costa, A. N., Bosi, A., Sacchi, S., Lombardini, L., Pupella, S., Lecchi, L., Calderon Garciduenas, E. D., van Beckhoven, J. M., de Wit, H. J. C., Fibbe, W. E., ... Regan, F. (2008). Cord blood banking. Vox Sanguinis, 95, 335-348. doi:10.1111/j.1423-0410.2008.01106.x

Bovy, C., Baudoux, E., Salmon, J., & Beguin, Y. (2006). Increased iron absorption during autologous blood donation supported by recombinant human erythropoietin therapy. Transfusion, 46 (9), 1616-23. doi:10.1111/j.1537-2995.2006.00945.x

Baron, F., Copizza, S., Baudoux, E., Jerusalem, G., Fillet, G., & Beguin, Y. (2004). CD34+ cell dose predicts costs after autologous peripheral blood stem cell transplantation for breast cancer. Haematologica, 89 (9), 1146-8.

Andre, M., Baudoux, E., Bron, D., Canon, J.-L., D'Hondt, V., Fassotte, M.-F., D'Hondt, L., Fillet, G., Humblet, Y., Jerusalem, G., Vermeulen, P., Symann, M., & Beguin, Y. (2003). Phase III randomized study comparing 5 or 10 microg per kg per day of filgrastim for mobilization of peripheral blood progenitor cells with chemotherapy, followed by intensification and autologous transplantation in patients with nonmyeloid malignancies. Transfusion, 43 (1), 50-7. doi:10.1046/j.1537-2995.2003.00273.x

Baron, F., Baudoux, E., Frere, P., Tourqui, S., Schaaf-Lafontaine, N., Herens, C., De Prijck, B., Fillet, G., & Beguin, Y. (2003). Low T-cell chimerism is not followed by graft rejection after nonmyeloablative stem cell transplantation (NMSCT) with CD34-selected PBSC. Bone Marrow Transplantation, 32 (8), 829-34. doi:10.1038/sj.bmt.1704220

Baron, F., Frere, P., Baudoux, E., Sautois, B., Fillet, G., & Beguin, Y. (2003). Non-myeloablative stem cell transplantation with low-dose total body irradiation and fludarabine for metastatic renal cell carcinoma. Haematologica, 88 (4), 478-80.

Baron, F., Frere, P., Baudoux, E., Schaaf-Lafontaine, N., Fillet, G., & Beguin, Y. (2003). Low incidence of acute graft-versus-host disease after non-myeloablative stem cell transplantation with CD8-depleted peripheral blood stem cells: an update. Haematologica, 88 (7), 835-7.

Baron, F., Schaaf-Lafontaine, N., Humblet-Baron, S., Meuris, N., Castermans, E., Baudoux, E., Frere, P., Bours, V., Fillet, G., & Beguin, Y. (2003). T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantation. Transplantation, 76 (12), 1705-13. doi:10.1097/01.TP.0000093987.11389.F7

Baron, F., Baudoux, E., Fillet, G., & Beguin, Y. (2002). Retrospective comparison of CD34-selected allogeneic peripheral blood stem cell transplantation followed by CD8-depleted donor lymphocyte infusions with unmanipulated bone marrow transplantation. Hematology, 7 (3), 137-43. doi:10.1080/1024533021000008173

Baron, F., Baudoux, E., Frere, P., Tourqui, S., Schaaf-Lafontaine, N., Greimers, R., Herens, C., Fillet, G., & Beguin, Y. (2002). Nonmyeloablative stem cell transplantation with CD8-depleted or CD34-selected peripheral blood stem cells. Journal of Hematotherapy and Stem Cell Research, 11 (2), 301-14. doi:10.1089/152581602753658484

Baron, F., Sautois, B., Baudoux, E., Matus, G., Fillet, G., & Beguin, Y. (2002). Optimization of recombinant human erythropoietin therapy after allogeneic hematopoietic stem cell transplantation. Experimental Hematology, 30 (6), 546-54. doi:10.1016/S0301-472X(02)00795-6

Baron, F., Siquet, J., Schaaf-Lafontaine, N., Baudoux, E., Hermanne, J.-P., Fillet, G., & Beguin, Y. (2002). Pre-emptive immunotherapy with CD8-depleted donor lymphocytes after CD34-selected allogeneic peripheral blood stem cell transplantation. Haematologica, 87 (1), 78-88.

Engelfriet, C. P., Reesink, H. W., Wagner, J. E., Kogler, G., Rocha, V., Wernet, P., Lecchi, L., Lazzari, L., Ratti, I., Giovanelli, S., Poli, F., Rebulla, P., Beguin, Y., Baudoux, E., Navarrete, C., Armitage, S., Laughlin, M. J., & McClelland, W. M. (2002). International forum. Use of umbilical cord blood progenitor cells as an alternative for bone marrow transplantation. Vox Sanguinis, 83 (2), 172-87. doi:10.1046/j.1423-0410.2002.00197.x

Sautois, B., Baudoux, E., Salmon, J., Michaux, S., Schaaf-Lafontaine, N., Pereira-Martins, M., Paulus, J.-M., Fillet, G., & Beguin, Y. (2001). Administration of erythopoietin and granulocyte colony-stimulating factor in donor/recipient pairs to collect peripheral blood progenitor cells (PBPC) and red blood cell units for use in the recipient after allogeneic PBPC transplantation. Haematologica, 86 (11), 1209-18.

Baudoux, E., Blaffart, F., Bouffioux, C., Caprasse, M., Courtois, F., Cremasco, M.-R., De Pasqual, E., Fassotte, M.-F., Gillet, P., Lamy, M., Larbuisson, R., Lemaire, R., Merciny, M., Moutschen, M., Radermecker, M., Remy, B., & Sondag, D. (2000). La commission d'hemovigilance du CHU. Revue Médicale de Liège, 55 (9), 878-80.

Fraipont, V., Sautois, B., Baudoux, E., Pereira-Martins, M., Fassotte, M.-F., Hermanne, J. P., Jerusalem, G., Longree, L., Schaaf-Lafontaine, N., Fillet, G., & Beguin, Y. (2000). Successful mobilization of peripheral blood HPCs with G-CSF alone in patients failing to achieve sufficient numbers of CD34+ cells and/or CFU-GM with chemotherapy and G-CSF. Transfusion, 40 (3), 339-47. doi:10.1046/j.1537-2995.2000.40030339.x

Salmon, J., Michaux, S., Hermanne, J. P., Baudoux, E., Gerard, C., Sondag, D., Fillet, G., & Beguin, Y. (1999). Delayed massive immune hemolysis mediated by minor ABO incompatibility after allogeneic peripheral blood progenitor cell transplantation. Transfusion, 39 (8), 824-7. doi:10.1046/j.1537-2995.1999.39080824.x

Sautois, B., Fraipont, V., Baudoux, E., Fassotte, M.-F., Hermanne, J. P., Jerusalem, G., Bours, V., Bosquee, L., Schaaf-Lafontaine, N., Paulus, J.-M., Sondag, D., Fillet, G., & Beguin, Y. (1999). Peripheral blood progenitor cell collections in cancer patients: analysis of factors affecting the yields. Haematologica, 84 (4), 342-9.

Baudoux, E., Margraff, U., Coenen, A., Jacobs, X., Deboutez, M., Lungu, C., & Sondag-Thull, D. (1998). Hemovigilance: Clinical Tolerance of Solvent-Detergent Treated Plasma. Vox Sanguinis, 74 (Suppl 1), 237-9. doi:10.1111/j.1423-0410.1998.tb05479.x

Beguin, Y., Baudoux, E., Sautois, B., Fraipont, V., Schaaf-Lafontaine, N., Pereira-Martins, M., Paulus, J.-M., Sondag, D., & Fillet, G. (1998). Hematopoietic recovery in cancer patients after transplantation of autologous peripheral blood CD34+ cells or unmanipulated peripheral blood stem and progenitor cells. Transfusion, 38 (2), 199-208. doi:10.1046/j.1537-2995.1998.38298193106.x

Jacquet, M., LAMBERT, V., BAUDOUX, E., Muller, M., Kremers, P., & Gielen, J. (April 1996). Correlation between P450 CYP1A1 Indelibility, MsPI Genotype and Lung Cancer Incidence. European Journal of Cancer, 32A (10), 1701-1706.

GREGOIRE, C., DETRY, O., Jouret, F., BRIQUET, A., LECHANTEUR, C., BAUDOUX, E., Beguin, Y., & GIET, O. (2017). The use of mesenchymal stromal cells in solid organ transplantation. In The Biology and Therapeutic Application of Mesenchymal Cells (pp. 825-835). Hoboken, United States: John Willey & Sons, Inc.

GREGOIRE, C., Louis, E., BRIQUET, A., LECHANTEUR, C., BAUDOUX, E., GIET, O., Beguin, Y., & BARON, F. (2017). The role of mesenchymal stromal cells in the treatment of ulcerative colitis and Crohn’s disease. In The Biology and Therapeutic Application of Mesenchymal Cells (pp. 730-753). Hoboken, United States: John Wiley & Sons, Inc.

Van Beckhoven, J., BAUDOUX, E., Duffy, M., Elmoazzen, H., Elwood, N., Gluckman, E., Gomez, S., Korhonen, M., Maeck, J., Querol, S., Ruggeri, A., & Torrabadella, M. (2013). Cord Blood Banking: Cord blood management and evaluation: International networking. In W. Hwang, M. Boo, ... T. Bart (Eds.), A gift for life, WMDA handbook for blood stem cell donation (pp. 178-180). WMDA.

Baudoux, E., Janssens, M., Beguin, Y., Sondag, D., Fillet, G., & Lamy, M. (1993). Erythropoietin in surgery. In Proceedings of the 4th Regional Congress of the International Society of Blood Transfusion (pp. 213-217).

BAUDOUX, E., BEGUIN, Y., Benoit, Y., Billiet, J., Delforge, A., DEVOS, T., Latinne, D., Noens, L., Selleslag, D., Van Riet, I., VANDEKERCKHOVE, B., Vermylen, C., & Zachée, P. (2012). Cord blood for allogeneic use: Clinical and scientific aspects? (8784). Bruxelles, Belgium: Conseil Supérieur de la Santé.

Angenon, E., BAUDOUX, E., BEGUIN, Y., benoit, Y., Billiet, J., Delforge, A., Devos, T., Ferrant, A., KÖGLER, G., Latinne, D., Faucher, C., NAVARRETE, C., Noens, L., SELLESLAG, D., STRAETMANS, N., VAN RIET, I., & Zachée, P. (2011). Autologous cord blood use: Clinical and scientific aspects. (8677).